+1 858-523-8231
Login | Register
AA Blocks, Building Blocks, Catalysts, Inhibitors
Login | Register
Home Boronic Acids 1014613-40-1
1014613-40-1,MFCD28397687
Catalog No.:AA01BAIH

1014613-40-1 | 2-Hydroxy-s-[4-(tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]ethane-1-sulfonamido

Pack Size
Purity
Availability
Price(USD)
Quantity
  
100mg
98%
in stock  
$68.00   $48.00
- +
250mg
98%
in stock  
$113.00   $79.00
- +
1g
98%
in stock  
$305.00   $213.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA01BAIH
Chemical Name:
2-Hydroxy-s-[4-(tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]ethane-1-sulfonamido
CAS Number:
1014613-40-1
Molecular Formula:
C14H22BNO5S
Molecular Weight:
327.2042
MDL Number:
MFCD28397687
SMILES:
OCCNS(=O)(=O)c1ccc(cc1)B1OC(C(O1)(C)C)(C)C
Properties
Computed Properties
 
Complexity:
464  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
22  
Hydrogen Bond Acceptor Count:
6  
Hydrogen Bond Donor Count:
2  
Rotatable Bond Count:
5  

Downstream Synthesis Route

[1]Locationinpatent:schemeortableLiddle,John;Bamborough,Paul;Barker,MichaelD.;Campos,Sebastien;Chung,Chun-Wa;Cousins,RickP.C.;Faulder,Paul;Heathcote,MichelleL.;Hobbs,Heather;Holmes,DuncanS.;Ioannou,Chris;Ramirez-Molina,Cesar;Morse,MaryA.;Osborn,Ruth;Payne,JeremyJ.;Pritchard,JohnM.;Rumsey,WilliamL.;Tape,DanielT.;Vicentini,Giorgia;Whitworth,Caroline;Williamson,RickA.[BioorganicandMedicinalChemistryLetters,2012,vol.22,#16,p.5222-5226]

[2]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2009/112473,2009,A1Locationinpatent:Page/Pagecolumn74

[3]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-WO2005/30770,2005,A1Locationinpatent:Page/Pagecolumn28

[4]Baumann,Georg;Meckel,Tobias;Böhm,Kevin;Shih,Yung-Hsin;Dickhaut,Mirco;Reichardt,Torben;Pilakowski,Johannes;Pehl,Ulrich;Schmidt,Boris[JournalofMedicinalChemistry,2022,vol.65,#2,p.1265-1282]

[1]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-WO2005/30770,2005,A1Locationinpatent:Page/Pagecolumn28

[1]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2009/112473,2009,A1Locationinpatent:Page/Pagecolumn79

N-(2-hydroxyethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzenesulfonamide 
  1014613-64-9   
N-(2-hydroxyethyl)-4-(2-methyl-1H-pyrrolo2,3-bpyridin-4-yl)benzenesulfonamide 

[1]BioorganicandMedicinalChemistryLetters,2009,vol.19,p.2504-2508

[1]Locationinpatent:schemeortableLiddle,John;Bamborough,Paul;Barker,MichaelD.;Campos,Sebastien;Cousins,RickP.C.;Cutler,GeoffreyJ.;Hobbs,Heather;Holmes,DuncanS.;Ioannou,Chris;Mellor,GeoffW.;Morse,MaryA.;Payne,JeremyJ.;Pritchard,JohnM.;Smith,KathrynJ.;Tape,DanielT.;Whitworth,Caroline;Williamson,RichardA.[BioorganicandMedicinalChemistryLetters,2009,vol.19,#9,p.2504-2508]

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 1014613-40-1
914610-50-7

914610-50-7

 1073353-47-5

1073353-47-5

 1401222-64-7

1401222-64-7

 214360-51-7

214360-51-7

 486422-04-2

486422-04-2

 648905-63-9

648905-63-9
Building Blocks
More >
Tags:1014613-40-1 Molecular Formula|1014613-40-1 MDL|1014613-40-1 SMILES|1014613-40-1 2-Hydroxy-s-[4-(tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]ethane-1-sulfonamido